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Purpose: Prosthetic infection after aortic reconstructive surgery historically has been 
treated with extraanatomical bypass, graft excision, and aortic stump closure, but at the 
cost of substantial mortality and amputation rates. Alternatives to this strategy include in 
situ prosthetic replacement in the infected area, as well as autogenous reconstructions. 
Inherent o all of these procedures, however, is either the creation of an aortic stump, 
which carries a significant risk of subsequent blowout, or the placement of a bypass 
conduit in the infected field, thereby maintaining thepotential for subsequent infectious 
complications. To avoid such problems, we have used retroperitoneal in-line aortic 
bypass with polytetrafluoroethylene through clean tissue planes. 
Methods: Since 1987 we have treated 16 graft infections in this manner. The surgical 
approach consisted of obtaining retroperitoneal proximal aortic control outside of the 
infected field (above or below the renal arteries), followed by infrarenal division and 
oversewing of the distal aorta. A polytetrafluoroethylene bifurcated graft was then sewn 
to the proximal aorta and tunnelled through the psoas sheath laterally to the profunda 
femoris artery on the ipsilateral side and via the space of Retzius to the contralateral 
appropriate f moral vessel, so as to avoid any contact with the infected areas. After the 
closure of the wounds, a plastic barrier was placed over all incisions and the patient was 
placed supine. The old infected graft was removed transperitoneally. Extensive cultures 
were taken at various sites to demonstrate no cross-contamination. 
Results: All patients were followed-up clinically and with tagged white cell scans at 
6-month intervals. There were no immediate postoperative d aths and no amputations. 
One patient had a myocardial infarction and died at 5 months, and a second patient died 
at 2 months. Of  the remaining 14 patients, none had recurrent sepsis and all have had 
negative Indium-labeled white cell scans in follow-up. Eleven (78%) are still alive, with a 
mean follow-up of 32 months (range, 20 to 106 months). 
Conclusions: In-line aortic bypass for treatment of aortic graft infections yields excellent 
results and has become our treatment of choice in dealing with this difficult problem. 
(J Vasc Surg 1997;25:106-12.) 
The standard treatment for aortic graft infection 
entails complete prosthetic removal combined with 
revascularizafion f the legs. This strategy has typi- 
cally involved extraanatomic bypass and transabdom- 
inal graft removal performed simultaneously or at 
separate sittings. Although thought to represent a
"gold standard," this technique still results in signif- 
icant morbidity and mortality rates. A cumulative 
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analysis of recent reports hat employed this ap- 
proach cites an avcragc mortality rate of 21% and an 
amputation rate of 22.5%} As a result, many sur- 
geons have attempted to find alternative approaches 
to this difficult problem. Such methods couple graft 
excision with in situ reconstruction where autoge- 
nous, 2-4 prosthetic, s-7 or allograft s material is used as 
the conduit. In addition, isolated extracavitary aortic 
graft limb infections have been managed with either 
partial graft excision coupled with a bypass graft 
around the infectious process or complete graft pres- 
ervation. 9 Inherent to these traditional and newer 
innovative procedures, however, is either the cre- 
ation of an aortic stump, which carries the potential 
risk for subsequent blowout, the placement of a by- 
pass in the infected field, thereby maintaining the 
potential for subsequent infectious complications, or 
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the failure to remove all of the involved prosthesis, 
which may result in persistent infection. To avoid 
such problems, we have used retroperitoneal in-line 
aortic bypass with polytetrafluoroethylene (PTFE) 
through clean tissue planes, coupled with transab- 
dominal removal of the infected prosthesis. Herein, 
we present our experience in treating 16 aortic graft 
infections in this manner. 
PATIENTS AND METHODS 
Patients. Analysis of data from the computer- 
ized vascular egistry coupled with review of patient 
charts were performed for all patients who had aortic 
graft infection between 1987 and 1995. Patient in- 
formation included demographics, atherosclerotic 
risk factors, original surgery, time until presentation, 
symptoms, reoperative procedure, bacteriolgic data, 
30-day operative morbidity and mortality data, and 
long-term follow-up. 
During this time period, two additional ap- 
proaches in the management of aortic graft infection 
have been used. These entail either extraanatomic 
bypass and complete graft removal or partial graft 
excision with or without adjunctive bypass. The results 
of these experiences are also included within this study. 
Patient selection. All patients are studied before 
surgery with computed tomographic (CT) scans and 
arteriographic evaluation. Tagged leukocyte scans 
and gastrointestinal endoscopy are obtained in se- 
lected cases. The aortic in-line bypass is the proce- 
dure of choice for all aortic graft infections unless a 
contraindication exists. A relative contraindication to 
the procedure is the absence of an adequate unin- 
fected infrarenal aorta from which to perform a prox- 
imal anastomosis. This can be circumvented, how- 
ever, by suprarenal aortic clamping and bypass, 
coupled with renal revascularization procedures as 
necessary. Another relative contraindication relates 
to low virulence infections that appear to be confined 
to the most distal portion of an aortobifemoral graft. 
These cases have been managed with partial graft 
excision. Absolute contraindication to in-line bypass 
includes CT evidence of extensive infection at the 
proximal anastomosis such that it is not possible to 
prevent significant cross-contamination between the 
in-line bypass and the abscess cavity. Additionally, 
high-risk and unstable patients may be treated with 
an alternative procedure. 
Surgical technique. After induction of general 
endotracheal anesthesia, the patient is positioned in a 
right or left lateral decubitus position for a retroper- 
itoneal approach to the aorta. Typically, a left retro- 
peritoneal exposure is used because most original 
procedures had been performed via the transabdom- 
inal route. Cases in which the infected graft had been 
placed through the left flank arc managed with right 
retroperitoneal in-line bypass grafts. With the aid of a 
suction bean bag (Olympic Vac-Pac), patients arc 
positioned with the left chest elevated between 45 
and 60 degrees, and the pelvis rotated 20 to 30 
degrees relative to the plane of the table. The table 
break is positioned at the level of the iliac crest. A 
kidney rest is not required. 
In most cases, the skin incision originates at the 
lateral edge of the rectus abdominis muscle 5 cm 
below the umbilicus and extends obliquely through 
the tenth intercostal space to or beyond the posterior 
axillary line. After division of the musculature, the 
peritoneum and left kidney are swept medially and 
cephalad. The aorta is then approached above the 
level of the renal arteries by division of the left crus of 
the diaphragm. Such exposure allows for dissection 
of the aorta at or just below the renal arteries and 
does not result in violation of the infected field. With 
adequate length of the aorta, two clamps may be 
placed 1 cm apart below the renal arteries. Transec- 
tion of the aorta flush with the distal clamp creates a
neck for the new anastomosis. Multiple cultures and 
gram stains are taken of the aorta. The distal aorta is 
oversewn with a 3-0 polypropylenc suture. Should 
the original anastomosis border on the left renal 
arteries, however, the left crus is divided to permit 
access to the suprarenal orta. An in-line bypass may 
still be performed if technically feasible. I f  suprarenal 
aortic transection is needed, the aortic bypass proce- 
dure may be coupled with renal reimplantation or
bypass procedures. Though laborious, such tech- 
niques allow for performance of an in-line bypass 
with prevention of cross-contamination. 
Once the proximal anastomosis is completed, the 
graft limbs are tunneled through clean tissue planes 
to the appropriate vessel. The left graft limb may be 
tunneled laterally under the inguinal igament into 
the sartorius heath. Alternatively, the psoas fascia 
may be used as a path for the left graft limb. The 
right graft limb may be taken through the space of 
Retzius (prevesical space). This graft limb is then 
passed medially under the inguinal igament. Alter- 
natively, if this space has been traversed by infection, 
the right limb may be passed retroperitoneally over 
the inferior vena cava and out through a counter- 
incision made on the right side just above the antero, 
superior iliac spine. The graft limb is then routed 
laterally under the inguinal igament. 
Distal anastomoses are carried out at uninfected 
sites. Thus for infected aortofemoral grafts, a lateral 
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Table I. Risk factors 
Risk factor No. (%) of patients 
Heart disease 7 (44%) 
Diabetes 4 (25%) 
Hypertension 9 (56%) 
Smoker 14 (87%) 
approach to the profunda femoris or superficial fem- 
oral artery avoids contact with the contaminated 
field. Tube or aortoiliac graft processes may be man- 
aged with bypass grafts to the common femoral ar- 
teries or external lilac arteries. 
On completion of the in-line bypass, the wounds 
are closed and isolated by occlusive dressings. The 
infected graft is removed transabdominally with 
groin counter-incisions a  indicated. Six weeks of 
intravenous antibiotic therapy were given, and the 
patients remained on oral antibiotics for 6 months. 
Patients are then observed clinically, and tagged 
white cell scans are performed at 6-month intervals. 
RESULTS 
Aortic in-line bypass grafts. From 1987 to 
1995, 16 aortic in-line bypass procedures were per- 
formed. There were 11 men and five women with an 
average age of 62 years (range, 47 to 73 years). 
Atherosclerotic risk factors were as listed in Table I. 
Time until presentation averaged 5.7 years (range, 5 
months to 15 years). 
Fourteen of the 16 (88%) original procedures 
were via the transabdominal route (aortobifemoral, 
9; aortobiiliac, 4; tube, 1). The remaining two cases 
were done using a left retroperitoneal exposure (aor- 
tobifemoral, 1; aortobiiliac, 1). Clinical presentations 
(Table II) varied, but most (63%) had some sort of 
groin involvement. Twenty-five percent presented 
with gastrointestinal bleeding though none of these 
patients were grossly unstable. At operation, eight 
patients had evidence of an aortoenteric fistula or 
erosion. Seven patients had mixed gram-positive and 
gram-negative infections, three had Staphylococcus 
epidermidis only, three had Staphylococcus aureus 
only, two had both S. epidermidis and S. aureus, and 
one had only anaerobes. All reoperative procedures 
(Table III) entailed an i itial in-line revascnlarization 
followed by same day or staged removal of the in- 
fected graft. Operative time for the nonstaged proce- 
dures was 5.8 hours, with a range of 4.0 to 7.7 hours. 
Transfusion requirements in these patients were 3 
units of packed red blood cells, with a range of 0 to 6 
units of packed red blood cells. All patients with 
Table II. Clinical presentations 
Clinical presentation No. (%) of patients 
Groin process 
Sinus, mass, infection 7 (44%) 
Gastrointestinal bleeding 4 (25%) 
Sepsis 1 (6%) 
Graft occlusion I (6%) 
Combination of above 3 (19%) 
Total 16 
episodes of gastrointestinal bleeding had their aor- 
toenteric processes dealt with at the same sitting. The 
14 transabdominal cases were all treated with in-line 
PTFE bypass grafts through the left retroperito- 
neum, followed by transabdominal graft removal 
(seven same sitting, seven staged). One patient re- 
quired right renal artery reconstruction and two re- 
quired reimplantation of the left renal artery. The 
majority of distal reconstructions were performed to 
the profunda femoris artery (7). The remainder were 
anastomosed to the common femoral artery (4), su- 
perficial femoral artery (3), and external iliac artery 
(2). Twelve anastomoses were performed in an end- 
to-side fashion, and four were end-to-end. A right 
retroperitoneal ccess was used in dealing with the 
other two cases done originally through the left 
flank. Both of these original operations, performed 
for occlusive disease, left enough infrarenal aorta 
such that an in-line bypass procedure could be per- 
formed through the right retroperitoneum. In
three patients an in-line reconstruction could not 
be performed. Two were hemodynamically unsta- 
ble at presentation, and a third had extensive prox- 
imal anastomotic nfection that prohibited in-line 
reconstruction. 
There were no immediate postoperative deaths 
and no amputations. Two significant complications 
did occur (one duodenal tear, one nccrorizing fasci- 
iris). Both of these patients went on to die, one 
related to sepsis at 2 months and the other of a 
myocardial infarction at 5 months. The patient with 
persistent sepsis had an unrecognized duodenal te r. 
Cultures of the aortic graft during his hospitalization 
and at postmortem were all negative. Follow-up has 
averaged 32 months (range, 2 to 106 months) in the 
remaining 14 patients. Eleven (78%) are still alive 
with no episodes of recurrent graft infection. Four 
patients (28%) had isolated graft limb thromboses 
that required surgical intervention. One (7%) of 
these patients, who had severe multilevel disease and 
needed an infrainguinal bypass at the time of the 
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in-line bypass, required an above-knee amputation. 
At the time of these operations, infection was not 
clinically evident. Results of all surveillance tagged 
white cell scans have been negative. 
Extraanatomic bypass and complete graft re- 
moval. From 1984 to 1995, 12 patients have un- 
dergone extraanatomic bypass coupled with com- 
plete graft removal. Mean age was 68 years (range, 
45 to 80 years). These patients tended to present 
earlier than the in-line bypass group (average, 3.6 
years). Follow-up ranged from 1 to 144 months, 
with a mean of 51 months. Again, clinical presenta- 
tions varied. Five patients (42%) had a septic compo- 
nent. There were three (24%) perioperative deaths, 
all related to sepsis. One additional patient died 4 
months after surgery. The remaining eight patients 
did well without any episodes of graft infection or 
limb loss. 
Partial graft excision with or without revascu- 
larization. From 1987 to 1995, partial excision of 
the infected grafts were performed in nine patients. 
This nine-patient subgroup averaged 66 years in age. 
Seven (78%) had some type of groin process, either a 
pseudoaneurysm (four patients) or groin drainage 
(three patients). Five (50%) were managed with par- 
tial graft excision and bypass around the infected 
field, whereas the other four patients were treated 
only with partial graft excision. No perioperative 
deaths occurred. Patient follow-up ranged from 3 to 
34 months, with a mean of 11 months. One patient 
died 7 months after surgery. The other eight patients 
did well with no known episodes of reinfection or 
limb loss. 
DISCUSSION 
Whereas isolated extracavitary infections of aortic 
prostheses may be managed with selective or com- 
plete preservation of the graft, 9intracavity aortic by- 
pass infections mandate graft excision coupled with a 
revascularization procedure to the legs. Management 
has traditionally consisted of total graft removal and 
extraanatomic bypass, graft removal alone with selec- 
tive revascularization based on clinical assessment of
limb viability, or partial graft removal with extraana- 
tomic bypass. Such cases have been performed in 
combined or staged fashions with revascularization 
before or after graft removal. Of all these variations, 
it appears that extraanatomic bypass followed by 
staged complete graft removal affords the best re- 
sults. Reilly et al?0 have the largest experience with 
this approach, reporting a 16% mortality rate and 
23% amputation rate. Even with the implementation 
of this "best case" scenario, however, the risk for 
Table II I .  Reoperative procedures 
No. (%) of patients 
Procedure Staged Combined 
Left retroperitoneal in-line aortobifemoral 2 (12%) 7 (44%) 
bypass and transabdominal graft 
removal 
Left retroperitoneal in-line aortobifemoral 2 (12%) 0 
bypass plus left renal artery 
reimplantation a d transabdominal 
graft removal 
Left retroperitoneal in-line aortobifemoral 1 (6%) 0 
bypass plus in situ femoroposterior 
tibial bypass and transabdominal graft 
removal 
Left retroperitoneal in-line aortobiiliac 0 2 (12%) 
(ext. iliac arteries) bypass and 
transabdominal graft removal 
Right retroperitoneal in-line 2 (12%) 0 
aortobifemoral bypass and 
transabdominal graft removal 
aortic stump blowout still exists. O'Hara et al. 11 in a 
large report note that aortic stump blowout ac- 
counted for 32% of the deaths of patients who under- 
went surgery for aortoenteric fistulas. Creative tech- 
niques to buttress the stump (i.e. jejunal patch, 12 
omental patch, 13 prevertebral fascia flap 14) may 
lessen the risk of blowout but do not avoid it entirely. 
Vascular surgeons' .unhappiness with double- 
digit complication rates has provided the impetus to 
develop alternative strategies in managing infected 
aortic grafts. Such techniques combine infected graft 
removal with autogenous, prosthetic, or allograft in 
situ conduit replacement. Autogenous in situ recon- 
structions employ various conduits such as native 
endarterectomized aortoiliac vessels, iliac or com- 
mon femoral arteries, and superficial or deep veins of 
the lower extremities. 2-4 Most recently, Clagett et 
al. 2 reported a20 patient experience with creation of 
a neo-aortoiliac system from lower extremity deep 
and superficial veins. In-hospital mortality and am- 
putation rates of 10% support its efficacy, although 
conduit stenosis i  of concern with greater saphenous 
vein reconstructions and chronic limb edema may 
complicate deep vein harvests. In situ bypass proce- 
dures with prosthetics have gained popularity in cer- 
tain centers, -7 Key to embarking on such a proce- 
dure is an assessment of the severity of graft 
infection. Jacobs et al. 6 demonstrated that in situ 
bypass grafts of severe aortic graft infections were 
prone to reinfection (6 patients, 100% reinfection 
and 83% mortality rates), whereas low virulent pro- 
cesses could be bypassed safely (12 patients, no rein- 
fection or death). These observations are echoed in 
the report o f  Bandyk, 7 who successfully treated 17 
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coagulase-negative staphylococcal graft infections (a
low virulence organism). Thus, prosthetic in situ 
bypass procedures afford good results when the op- 
erative field is not grossly contaminated. In highly 
contaminated cases, cadaveric allograft may be more 
resistant to reinfection. 8 
Although an in situ prosthetic reconstruction 
avoids creation of an aortic stump and achieves good 
results in relatively uncontaminated cases, it is not as 
durable in high virulence situations. This probably 
relates to its placement in an infected field. To avoid 
both creation of an aortic stump and traversing in an 
infected field, we have managed intracavitary and 
severe xtracavitary aortic graft infections with retro- 
peritoneal in-line PTFE bypass through clean tissue 
planes, followed by transabdominal graft removal, is
We define severe extracavitary infections as high- 
virulence situations, cases in which the entire graft 
limb appears to be involved with infection, or any 
time when there is a question of intracavitary graft 
involvement. No 30-day deaths and only two (12%) 
early deaths speak to its ability to be safely per- 
formed. Moreover, of the 14 long-term survivors, 
only one (7%) has required an amputation, and no 
episodes of reinfection have become vident. 
Theoretically, certain conditions are to be satis- 
fied for the performance ofin-line bypass for infected 
aortic grafts. An adequate amount of the uninfected 
aorta should be present between the proximal in- 
fected suture line and renal artery to allow for clean 
division and anastomosis. In one instance, however, 
proximal anastomotic nfection that abutted the left 
renal artery was dealt with by suprarenal clamping, 
transection of the aorta above the left renal but 
below the right, followed by aortic anastomosis with 
left renal reimplantation. On another occasion, a 
patient who had a prior left nephrectomy and an 
aortic graft infection extending to the right renal 
artery was approached initially with a transabdominal 
hepatorenal bypass, followed by retroperitoneal su- 
prarenal aortic transection and bypass, and finally 
transabdominal graft removal. In-line bypass proce- 
dures are contraindicated in cases where the CT 
appearance of the infectious process uggests that it 
would not be possible to stay out of the abscess cavity 
when placing the new graft. The patient should be in 
a relatively stable condition so that the clean part of 
the operation can be performed first, before tending 
to aortic bleeding when a fistula exists. Routing of 
the graft limbs usually does not pose a major prob- 
lem because careful planning allows graft placement 
through clean areas. 
CONCLUSION 
Retroperitoneal PTFE in-line aortic bypass for 
aortic graft infection has provided satisfactory early 
results with no deaths at 1 month. Follow-up from 2 
months to 8.5 years reveal that only one patient 
required amputation and reveal no evidence of rein- 
fection. When technically feasible, it is our treatment 
of choice in dealing with aortic graft infections. 
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DISCUSSION 
Dr. Louis M. Messina (San Francisco, Calif.). The 
Albany group, which is headed by Drs. Leather and Shah, 
was well represented by this excellent presentation by Dr. 
Darling. He gave a comprehensive r view of their alterna- 
tive method of treating aortic graft infection. Their experi- 
ence with retroperitoneal graft exclusion for aneurysm is 
now being extended to selective treatment of prosthetic 
graft infection. They use an in-line retroperitoneal ort- 
ofemoral bypass procedure, followed by traditional trans- 
abdominal aortic graft exclusion. At first glance, it suggests 
a risk of contamination f the new prosthesis, which would 
defeat he concept entirely. However, their follow-up ex- 
perience in 14 survivors, 11 of whom were observed after 
surgery for a mean of 32 months without recurrent infec- 
tion, is commendable. But it is nonetheless a relatively 
short follow-up period, It does challenge historic treat- 
ment of aortic graft infection, extraanatomic bypass, and 
staged or simultaneous transabdominal graft removal, of 
which we at the University of California,-San Francisco, 
have been strong advocates. 
We are places to see these challenges. They may prove 
to be successful over a longer follow-up period, but clearly 
these challenges encourage us to reexamine the traditional 
method of treatment to improve the outlook for any pa- 
tients who are threatened by graft infection. The Albany 
group's in-line aortofemoral grafting technique performed 
retroperitoneally offers two important features that are not 
present in the historic approach: it maintains an aortic- 
based perfusion of the limbs; and it avoids the late threat of 
extraanatomic bypass failure. 
Their experience has its shortcomings. And this is not 
meant o flaw their approach for their treatment of aortic 
graft infection. Their series is small and involves a carefully 
selected group of 16 patients among 37 patients who had 
graft infections treated in the past decade at their institu- 
tion. They provide the selection criteria that they use to 
identify appropriate candidates for their approach. In es- 
sence, the graft infection cannot be too limited or too 
extensive, only just right. 
Conduct of the operation requires knowledge ofretro- 
peritoneal anatomy and precision in reoperative proce- 
dures. This experienced group has two surgical complica- 
tions: one a duodenal laceration and the other necrotizing 
fasciitis, both of which proved fatal 2 and 5 months later. 
Their graft limb occlusion rate was 28% during a 32-month 
follow-up period, but all were successfully revised. 
We have the following questions for you, Dr. Darling: 
How much uninfected aorta is enough to use for a retro- 
peritoneal approach? What measures do you suggest o 
improve outcome for septic patients, who had a 60% mor- 
tality rate in your historic group? What imaging technology 
do you prefer for retroperitoneal graft infection and why? 
What has convinced you of the reliability of white blood 
cell scans? Because persistent infection of the aorta is an 
important mechanism of aortic stump disruption, how 
does your technique reduce the likelihood of this compli- 
cation? 
The authors propose a new preferred treatment for 
selected patients who have aortic graft infection. The 
manuscript will be an important published article to review 
for those of you who treat hese patients. 
Dr. IL Clement Darl ing I I I .  I want to thank you, Dr. 
Messina, for your kind comments, and our thoughts go 
out to Dr. Stoney and his family. 
We have had an extensive xperience with retroperito- 
neal dissection, and this experience combined with our 
exclusion data has helped us in being able to decide which 
patients would be appropriately treated with this therapy. 
Originally we tried to limit the patients to assure that we 
could perform this operation safely in this very sick patient 
population. However, as we became more comfortable 
with this exposure, all we need is enough aorta to place two 
clamps, hopefully inftarenally; however, again, as we be- 
come more comfortable, we're happy with placing the 
clamps uprarenally aslong as we stay out of the previously 
infected field. 
On the left side, placing the clamps in a suprarenal 
position does not offer a problem at all, as the posterolat- 
eral retroperitoneal approach offers exposure of the visceral 
aorta from the diaphragm. If one really looks at it critically, 
the amount of aorta one needs after debridement to per- 
form an aortic stump closure is probably less than one 
needs to perform a proximal anastomosis. 
On the right side, we have been much more judicious 
about performing this operation when patients have un- 
dergone previous procedures in which left retroperitoneal 
approaches were used. We narrowed this down to patients 
who had occlusive disease and probably 2 or 3 cm of aorta 
because proximal exposure through the right retroperito- 
neal approach can be a little bit more arduous. The vena 
cava on this side has not caused us any problems whatso- 
ever. 
One of the reasons we tried to develop an alternative 
approach was the unhappiness we had with the significant 
complication rates reported with the classic approach. Un- 
fortunately, I think that the only way to improve these 
patients' condition is by removing their infective nidus as 
quickly as possible while reinstituting blood flow to the 
legs. And that's why we are relatively aggressive with taking 
these patients to the operating room after we have an 
appropriate preoperative workup. The tagged white cell 
scan we have used as an adjunct, and probably more for our 
own security than anything, and the data on that are not 
very well documented. We use it to evaluate the extent of 
the infection, to see whether it is just confined to the groin 
or to see whether it extends more proximally. But possibly 
these data may be obtained from the CT scan as well. 
Imaging technology, such as the CT scan and the 
angiogram, give us an anatomic location for the extent of 
the infection and also allows us to make an operative plan. 
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The most important part of this entire operation is to have 
a cohesive operative plan outlined before embarking on the 
operation. This is not the type of operation during which 
you should be making too many decisions in the operating 
room.  
The white blood cell scan, as I mentioned, is not 
fool-proof, and we're still looking at our data to make sure 
that this is a reasonable test for follow-up; however, the 
only way to accumulate these data is to perform them at 
intervals and evaluate your results. 
Dr. Alec N. Simpson (South Plainfield, N.J.). You 
mentioned that you assumed that the aorta had been re- 
paired originally with a transabdominal approach, and as 
you in Albany have done a lot of retroperitoneal ortic 
resections, and I imagine a lot of us out here in the 
community have too, would you not then use this similar 
approach for a retroperitoneally repaired aortic aneurysm? 
Dr. Darling. Aneurysms offer a quite difficult problem 
because most of the anastomoses are fairly proximal. How- 
ever, if you can still obtain proximal aortic exposure 
through a clean tissue plane, either through a transthoracic 
incision or a high retroperitoneal incision, the ability to 
perform the procedure depends on the anatomy of the 
patient. Again, if there is enough uninfected or uninvolved 
aorta, we would use a right retroperitoneal pproach. 
However, that decision would be made in advance of 
surgery, knowing that we have an adequate l ngth of aorta. 
Mr. John H. N. Wolfe (London, England). I think 
one of the problems that we have with this difficult opic is 
that the criteria re poorly defined. We have recently pub- 
lished a study of 50 patients with aortic graft infection who 
underwent either minor procedures or underwent removal 
of the entire graft and an extraanatomic bypass procedure. 
In that series the prosthetic graft invariably eventually re- 
quired removal, so no prostheses were left in the abdomen. 
In your patients, however, many may have had a well- 
incorporated aortic graft and graft limb infection in the 
groin. In situ replacement under these circumstances may 
be appropriate. But I would suggest to you that if there is 
gross infection of the aortic graft overlying the aorta, then 
it is very unlikely that you are going to avoid contamina- 
tion of your new graft and that you will eventually see 
further infection. So do you think there is a difference 
between patients with a groin infection and those whom 
have a gross infection of the entire graft up to the level of 
the renal arteries? 
Dr. Darling. Thank you very much for your question. 
I think there is a difference. We try to treat patients elec- 
tively. If  the infection follows the entire aortic graft, as long 
as we can stay superior to this area nd have a barrier of 
some tissue between the old graft and the new graft, we 
have been satisfied. This is the rationale for obtaining 
multiple specimens for cultures at the proximal neck and in 
the proximal field. The results of the gram stains performed 
have been negative for any organisms in all cases. 
A three-and-a-half year follow-up period is relatively 
short; however, we have had no reinfections so far. How- 
ever, we still have to keep observing these patients for the 
long term to see whether this will be a useful procedure. So 
far, we have been very satisfied with the technique and have 
never encountered the graft with proximal exposure or 
anastomosis, and so this has really not been a problem for 
us. However, if we found that there was a large phlegmon 
or a large infected pseudoaneurysm proximally, we would 
probably not perform this type of reconstruction. 
One of the problems is also that when we performed 
the axillofemoral bypasses, we have had to convert half of 
those patients back to aortic-based bypass procedures be- 
cause of failure, and that again was one of the precipitants 
for us to develop this procedure. 
Dr. Richard H.  Dean (Winston-Salem, N.C.). One of 
the points that I do not think you made in your conclu- 
sions but that is clearly, at least from our experience, a very 
valid observation, is that the lower the graft is positioned, 
the higher the probability of some complication occurring, 
because there is a higher probability that it has been im- 
planted by an occasional vascular surgeon. And what you 
have not said is that a lot of your graft infections are in 
grafts that have been placed low on the aorta where they 
shouldn't be, but where it hankfully gives us an opportu- 
nity to do something less complex in a majority of them. I f  
the bypass grafting procedure is performed by somebody 
who really knows what they are doing, the grafts are stuck 
right up there at the renal arteries, and there isno way that 
you would have that space. But, thankfully, that's an un- 
common occurrence. 
